Agendia

About:

Agendia provides molecular diagnostics and personalized treatment plans for cancer patients.

Website: http://www.agendia.com

Twitter/X: Agendia

Top Investors: Debiopharm Group, Korys, Ardian, EASME - EU Executive Agency for SMEs, ING Group

Description:

Agendia's molecular diagnostic technology provides cancer patients and their physicians with a glimpse into their genome, answers to the most pressing questions and enables personalized treatment plans. Agendia’s breast cancer tests were developed using an unbiased gene selection by analyzing the complete human genome. Agendia’s tests can help physicians assess a patient’s individual risk for metastasis, which patients may benefit from chemo, hormonal or combination therapy, and which patients may not require these treatments and can instead be treated with other, less arduous and less costly methods.